← Back to Clinical Trials
RecruitingNCT06756100

Early Inflammatory Bowel Disease Progression

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionInflammatory Bowel Diseases
SponsorPontificia Universidad Catolica de Chile
Study TypeOBSERVATIONAL
PhaseN/A
Enrollment140
SexALL
Min Age18 Years
Max Age100 Years
Start Date2023-07-07
Completion2027-04

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.

Eligibility Criteria

Inclusion Criteria: * Adult patients with with at least 3 weeks of gastrointestinal symptoms including diarrhea, rectal bleeding, abdominal pain, tenesmus or urgency Exclusion Criteria: * Confirmed infectious disease of the gastrointestinal tract

Related Trials